- Home
- RCKT vs NRP Comparison
RCKT vs NRP Comparison
Compare RCKT & NRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- NRP
- Stock Information
- Founded
- RCKT 1999
- NRP 2002
- Country
- RCKT United States
- NRP United States
- Employees
- RCKT N/A
- NRP N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- NRP Coal Mining
- Sector
- RCKT Health Care
- NRP Energy
- Exchange
- RCKT Nasdaq
- NRP Nasdaq
- Market Cap
- RCKT 1.3B
- NRP 1.4B
- IPO Year
- RCKT N/A
- NRP N/A
- Fundamental
- Price
- RCKT $10.31
- NRP $107.24
- Analyst Decision
- RCKT Strong Buy
- NRP
- Analyst Count
- RCKT 11
- NRP 0
- Target Price
- RCKT $50.27
- NRP N/A
- AVG Volume (30 Days)
- RCKT 1.8M
- NRP 41.9K
- Earning Date
- RCKT 02-24-2025
- NRP 03-06-2025
- Dividend Yield
- RCKT N/A
- NRP 2.80%
- EPS Growth
- RCKT N/A
- NRP 4.50
- EPS
- RCKT N/A
- NRP 12.60
- Revenue
- RCKT N/A
- NRP $256,666,000.00
- Revenue This Year
- RCKT N/A
- NRP N/A
- Revenue Next Year
- RCKT $240,645.72
- NRP N/A
- P/E Ratio
- RCKT N/A
- NRP $8.51
- Revenue Growth
- RCKT N/A
- NRP N/A
- 52 Week Low
- RCKT $10.12
- NRP $81.74
- 52 Week High
- RCKT $31.47
- NRP $113.04
- Technical
- Relative Strength Index (RSI)
- RCKT 32.27
- NRP 50.70
- Support Level
- RCKT $10.12
- NRP $105.00
- Resistance Level
- RCKT $11.24
- NRP $111.00
- Average True Range (ATR)
- RCKT 0.71
- NRP 4.29
- MACD
- RCKT -0.09
- NRP -0.12
- Stochastic Oscillator
- RCKT 5.88
- NRP 43.95
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About NRP Natural Resource Partners LP Limited Partnership
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. The business activity of the group functions through the United States.